Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 26, 2025 Filed Feb 26, 2025 20:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · derivative · entry 11

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 26, 2025 Filed Feb 26, 2025 20:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,771 $0.00 Strike: $56.37 $0.00
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · derivative · entry 10

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,771 shares

Expires 2025-11-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 26, 2025 Filed Feb 26, 2025 20:30 UTC SaleCommon Stock 3,141 $237.15 $744,898.20
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 6

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,510

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.41, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 26, 2025 Filed Feb 26, 2025 20:30 UTC SaleCommon Stock 2,690 $237.15 $637,942.11
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 5

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,651

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.41, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 26, 2025 Filed Feb 26, 2025 20:30 UTC SaleCommon Stock 2,574 $237.15 $610,432.34
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 4

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,341

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.41, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 26, 2025 Filed Feb 26, 2025 20:30 UTC Exercise / conversionCommon Stock 4,107 $88.66 $364,126.62
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 3

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 26, 2025 Filed Feb 26, 2025 20:30 UTC Exercise / conversionCommon Stock 4,753 $64.89 $308,422.17
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 2

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 26, 2025 Filed Feb 26, 2025 20:30 UTC Exercise / conversionCommon Stock 5,771 $56.37 $325,311.27
Disclosure

SEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2025 Filed Feb 6, 2025 18:49 UTC
keller brettDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 5,771 $0.00 Strike: $56.37 $0.00
Disclosure

SEC source: 0001225208-25-001319 · doc4.xml · derivative · entry 6

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,771 shares

Expires 2025-11-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2025 Filed Feb 6, 2025 18:49 UTC
keller brettDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 3,087 $0.00 Strike: $51.43 $0.00
Disclosure

SEC source: 0001225208-25-001319 · doc4.xml · derivative · entry 5

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,087 shares

Expires 2025-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2025 Filed Feb 6, 2025 18:49 UTC
keller brettDirector
SaleCommon Stock 3,566 $240.40 $857,266.76
Disclosure

SEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 4

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,536

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.55 - $241.0763, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 06, 2025 Filed Feb 6, 2025 18:49 UTC
keller brettDirector
SaleCommon Stock 1,876 $240.40 $450,990.59
Disclosure

SEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 3

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,102

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.55 - $241.0763, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 06, 2025 Filed Feb 6, 2025 18:49 UTC
keller brettDirector
Exercise / conversionCommon Stock 3,087 $51.43 $158,764.41
Disclosure

SEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,978

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2025 Filed Feb 6, 2025 18:49 UTC
keller brettDirector
Exercise / conversionCommon Stock 5,771 $56.37 $325,311.27
Disclosure

SEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 17:11 UTC
Ghei AshimaInterim CFO
GrantStock Option (Right to Buy) · Derivative 14,137 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001232 · doc4.xml · derivative · entry 1

Ghei Ashima · CIK 0002028322 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,137

Underlying: Common Stock · 14,137 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 17:11 UTC
Jarkowski Hope M.Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 12,473 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001234 · doc4.xml · derivative · entry 1

Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,473

Underlying: Common Stock · 12,473 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 12:11 UTC
Matlin LauraCVP, Deputy GC and CCO
GrantStock Option (Right to Buy) · Derivative 1,580 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001235 · doc4.xml · derivative · entry 2

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,580

Underlying: Common Stock · 1,580 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 12:11 UTC
Matlin LauraCVP, Deputy GC and CCO
SaleCommon Stock 514 $241.60 $124,180.76
Disclosure

SEC source: 0001225208-25-001235 · doc4.xml · nonDerivative · entry 1

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,601.696

Read SEC document
February 04, 2025 Filed Feb 5, 2025 17:11 UTC GrantStock Option (Right to Buy) · Derivative 110,601 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001233 · doc4.xml · derivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,601

Underlying: Common Stock · 110,601 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 12:11 UTC
DALY RICHARD JDirector · Executive Chairman
GrantStock Option (Right to Buy) · Derivative 4,241 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001230 · doc4.xml · derivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,241

Underlying: Common Stock · 4,241 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 17:11 UTC
Stingi Richard JohnCorporate VP and CHRO
GrantStock Option (Right to Buy) · Derivative 7,068 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001237 · doc4.xml · derivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,068

Underlying: Common Stock · 7,068 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 17:11 UTC GrantStock Option (Right to Buy) · Derivative 34,095 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001236 · doc4.xml · derivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,095

Underlying: Common Stock · 34,095 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 17:11 UTC GrantStock Option (Right to Buy) · Derivative 9,771 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001231 · doc4.xml · derivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,771

Underlying: Common Stock · 9,771 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 17:11 UTC
Carey Thomas PCorporate VP
GrantStock Option (Right to Buy) · Derivative 15,384 $0.00 Strike: $240.59 $0.00
Disclosure

SEC source: 0001225208-25-001229 · doc4.xml · derivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,384

Underlying: Common Stock · 15,384 shares

Expires 2035-02-04

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 77 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000529 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,284

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 8 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000530 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,166

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC
keller brettDirector
GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000531 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,120

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC
keller brettDirector
GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000531 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,107

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 4 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000535 · doc4.xml · nonDerivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,148

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000535 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,144

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC
Zavery AmitDirector
GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000534 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,418

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC
Zavery AmitDirector
GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000534 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,405

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 8 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000533 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,087

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 8 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000533 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,095

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 15 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000532 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,465.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 52 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000532 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,450.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2025 Filed Jan 10, 2025 20:29 UTC GrantCommon Stock 19 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000528 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,145

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 16:50 UTC
keller brettDirector
GrantCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010870 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,076

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 16:50 UTC GrantCommon Stock 188 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010872 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,138

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 16:50 UTC
Zavery AmitDirector
GrantCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010874 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,391

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 16:50 UTC GrantCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010873 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,079

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 16:50 UTC GrantCommon Stock 152 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010871 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,398.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 16:24 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 15,167 $0.00 Strike: $117.34 $0.00
Disclosure

SEC source: 0001225208-24-010522 · doc4.xml · derivative · entry 4

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,167 shares

Expires 2030-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 16:24 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 13,208 $230.32 $3,042,104.86
Disclosure

SEC source: 0001225208-24-010522 · doc4.xml · nonDerivative · entry 3

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,146

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.935 - $231.44, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 16:24 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 2,502 $230.32 $576,267.90
Disclosure

SEC source: 0001225208-24-010522 · doc4.xml · nonDerivative · entry 2

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,354

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.935 - $231.44, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 16:24 UTC
Carey Thomas PCorporate VP
Exercise / conversionCommon Stock 15,167 $117.34 $1,779,695.78
Disclosure

SEC source: 0001225208-24-010522 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 21, 2024 Filed Nov 22, 2024 13:12 UTC
DALY RICHARD JDirector · Executive Chairman
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010109 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,093.9949

F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to the Richard J Daly Foundation donor advised fund account.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantStock Option (Right to Buy) · Derivative 1,844 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009962 · doc4.xml · derivative · entry 5

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Common Stock · 1,844 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantCommon Stock 458 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009962 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,207

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantStock Option (Right to Buy) · Derivative 1,844 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009963 · doc4.xml · derivative · entry 2

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Common Stock · 1,844 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.